July 21, 2023 Comments Off on New patent for Glenmark Specialty drug RYALTRIS Posted in: Patent Added Annual Drug Patent Expirations for RYALTRIS Ryaltris is a drug marketed by Glenmark Specialty and is included in one NDA. It is available from one supplier. There are thirteen patents…
The post New patent for Glenmark Specialty drug RYALTRIS appeared f…
July 21, 2023 Comments Off on New patent for Fennec Pharms drug PEDMARK Posted in: Patent Added Annual Drug Patent Expirations for PEDMARK Pedmark is a drug marketed by Fennec Pharms Inc and is included in one NDA. It is available from one supplier. There are three…
The post New patent for Fennec Pharms drug PEDMARK appeared first on DrugPatentWa…
